These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12015870)

  • 21. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.
    Wohl AR; Garland WH; Valencia R; Squires K; Witt MD; Kovacs A; Larsen R; Hader S; Anthony MN; Weidle PJ
    Clin Infect Dis; 2006 Jun; 42(11):1619-27. PubMed ID: 16652320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and pitfalls of initial highly active antiretroviral therapy in HIV-infected patients in routine clinical practice.
    Moreno A; Perez-Elías MJ; Casado JL; Muñoz V; Antela A; Dronda F; Navas E; Fortún J; Quereda C; Moreno S
    Antivir Ther; 2000 Dec; 5(4):243-8. PubMed ID: 11142618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized comparison of two instruments for measuring self-reported antiretroviral adherence.
    Mannheimer S; Thackeray L; Huppler Hullsiek K; Chesney M; Gardner EM; Wu AW; Telzak EE; Lawrence J; Baxter J; Friedland G;
    AIDS Care; 2008 Feb; 20(2):161-9. PubMed ID: 18293124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A lopinavir/ritonavir-based once-daily regimen results in better compliance and is non-inferior to a twice-daily regimen through 96 weeks.
    Molina JM; Podsadecki TJ; Johnson MA; Wilkin A; Domingo P; Myers R; Hairrell JM; Rode RA; King MS; Hanna GJ
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1505-14. PubMed ID: 18160008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of antiretroviral regimen switches on adherence.
    Miller LG; Golin CE; Hays RD; Liu H; Beck CK; Kaplan AH; Wenger NS
    HIV Clin Trials; 2002; 3(5):355-60. PubMed ID: 12407484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
    Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective study of predictors of adherence to combination antiretroviral medication.
    Golin CE; Liu H; Hays RD; Miller LG; Beck CK; Ickovics J; Kaplan AH; Wenger NS
    J Gen Intern Med; 2002 Oct; 17(10):756-65. PubMed ID: 12390551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity of a stage of change instrument in assessing medication adherence in indigent patients with HIV infection.
    Rathbun RC; Farmer KC; Lockhart SM; Stephens JR
    Ann Pharmacother; 2007 Feb; 41(2):208-14. PubMed ID: 17213294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring.
    Arnsten JH; Demas PA; Farzadegan H; Grant RW; Gourevitch MN; Chang CJ; Buono D; Eckholdt H; Howard AA; Schoenbaum EE
    Clin Infect Dis; 2001 Oct; 33(8):1417-23. PubMed ID: 11550118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing baseline religious practices and beliefs to predict adherence to highly active antiretroviral therapy among HIV-infected persons.
    Vyas KJ; Limneos J; Qin H; Mathews WC
    AIDS Care; 2014; 26(8):983-7. PubMed ID: 24499276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved adherence with contingency management.
    Rosen MI; Dieckhaus K; McMahon TJ; Valdes B; Petry NM; Cramer J; Rounsaville B
    AIDS Patient Care STDS; 2007 Jan; 21(1):30-40. PubMed ID: 17263651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries.
    Wagner GJ
    AIDS Patient Care STDS; 2002 Dec; 16(12):599-608. PubMed ID: 12542933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence to antiretroviral treatment in patients with HIV in the UK: a study of complexity.
    Sherr L; Lampe F; Norwood S; Leake Date H; Harding R; Johnson M; Edwards S; Fisher M; Arthur G; Zetler S; Anderson J
    AIDS Care; 2008 Apr; 20(4):442-8. PubMed ID: 18449821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How well do clinicians estimate patients' adherence to combination antiretroviral therapy?
    Miller LG; Liu H; Hays RD; Golin CE; Beck CK; Asch SM; Ma Y; Kaplan AH; Wenger NS
    J Gen Intern Med; 2002 Jan; 17(1):1-11. PubMed ID: 11903770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to HIV antiretrovirals among persons with serious mental illness.
    Wagner GJ; Kanouse DE; Koegel P; Sullivan G
    AIDS Patient Care STDS; 2003 Apr; 17(4):179-86. PubMed ID: 12737641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electronic monitoring: adherence assessment or intervention?
    Wagner GJ; Ghosh-Dastidar B
    HIV Clin Trials; 2002; 3(1):45-51. PubMed ID: 11819185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy.
    Hardy H; Kumar V; Doros G; Farmer E; Drainoni ML; Rybin D; Myung D; Jackson J; Backman E; Stanic A; Skolnik PR
    AIDS Patient Care STDS; 2011 Mar; 25(3):153-61. PubMed ID: 21323532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.